Literature DB >> 6488712

Lack of hormonal changes in postmenopausal women of equal weight with and without osteoporosis, including relation to time of menopause.

H Rico, A Charro, I Depablos, E Bordiu, E R Hernandez, D Espinos.   

Abstract

The hormonal variations in postmenopausal osteoporosis are not precisely defined. The duration of the menopause and other factors, such as the weight of the patients, may be of significance. Having a basic criterion of uniformity in weight, sixty postmenopausal women were studied in regard to the following aspects: urinary hydroxyproline, estrone, estradiol, parathyroid hormone, thyroxine, triiodothyronine, thyroid stimulating hormone, cortisol and metacarpal cortical area/total area. They were divided into: Group A: 15 patients with osteoporosis and five years since menopause; Group B: 15 patients without osteoporosis (age-matched with group A); Group C: 15 patients with osteoporosis and more than ten years since menopause; and Group D: 15 patients without osteoporosis (age-matched with Group C). In the group with postmenopausal osteoporosis (A and C) there is a significant increase in urinary hydroxyproline/creatinine and a significant decrease of the cortical area/total area when we compared them with age-matched groups. The hormonal values do not vary significantly among the four groups. Ours results indicate an increase of bone resorption as a cause of postmenopausal osteoporosis. The hormonal variations, if any, cannot be related to basal values.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6488712     DOI: 10.1007/bf02032340

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  47 in total

1.  EFFECTS OF ANDROGENS, ESTROGENS AND HIGH CALCIUM INTAKES ON BONE FORMATION AND RESORPTION IN OSTEOPOROSIS.

Authors:  F W LAFFERTY; G E SPENCER; O H PEARSON
Journal:  Am J Med       Date:  1964-04       Impact factor: 4.965

2.  LOSS OF COMPACT BONE DUE TO MENOPAUSE.

Authors:  H E MEEMA; M L BUNKER; S MEEMA
Journal:  Obstet Gynecol       Date:  1965-09       Impact factor: 7.661

3.  Effect of glucocorticoids on function of the parathyroid glands in man.

Authors:  R F Fucik; S C Kukreja; G K Hargis; E N Bowser; W J Henderson; G A Williams
Journal:  J Clin Endocrinol Metab       Date:  1975-01       Impact factor: 5.958

4.  Adrenal steroids and the development of osteoporosis in oophorectomised women.

Authors:  S C Manolagas; D C Anderson; R Lindsay
Journal:  Lancet       Date:  1979-09-22       Impact factor: 79.321

5.  Skeletal renewal and metabolic bone disease.

Authors:  W H Harris; R P Heaney
Journal:  N Engl J Med       Date:  1969-01-23       Impact factor: 91.245

6.  Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis?

Authors:  H M Taggart; C H Chesnut; J L Ivey; D J Baylink; K Sisom; M B Huber; B A Roos
Journal:  Lancet       Date:  1982-02-27       Impact factor: 79.321

7.  [Is phosphodiesterase responsible for bone changes in thyroid dysfunction?].

Authors:  H Rico; J A Cabranes; M C Paniagua; E de Frutos; M Núñez-Torrón; I de Pablos; F Gómez-Castresana
Journal:  Med Clin (Barc)       Date:  1983-11-19       Impact factor: 1.725

8.  [Parameters of bone mass in the normal Spanish population].

Authors:  H Rico Lenza; A Del Rio Vazquez; C Lozano Tonkin; R Ciguenza Gabriel; D Espinos Pérez
Journal:  Rev Clin Esp       Date:  1978-03-15       Impact factor: 1.556

9.  Osteoporosis after oophorectomy for non-malignant disease in premenopausal women.

Authors:  J M Aitken; D M Hart; J B Anderson; R Lindsay; D A Smith; C F Speirs
Journal:  Br Med J       Date:  1973-05-12

10.  Postmenopausal osteoporosis. A heterogeneous disorder as assessed by histomorphometric analysis of Iliac crest bone from untreated patients.

Authors:  M P Whyte; M A Bergfeld; W A Murphy; L V Avioli; S L Teitelbaum
Journal:  Am J Med       Date:  1982-02       Impact factor: 4.965

View more
  1 in total

1.  Total and regional bone mineral content in women treated with GnRH agonists.

Authors:  H Rico; F Arnanz; M Revilla; S Perera; M Iritia; L F Villa; I Arribas
Journal:  Calcif Tissue Int       Date:  1993-05       Impact factor: 4.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.